Skip to main content

Table 3 Response Assessment

From: Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma

Response

N

%

Number of patients

33

100%

Number of patients with:

  

   CR

1

3%

   PR

2

6%

   SD > 8 weeks

6

18%

   SD ≤ 8 weeks

9

27%

   PD

15

45%

Tumor Growth Control (90% CI)

9

27% (13% - 46%)

Overall Response Rate (90% CI)

3

9% (3% - 22%)

  1. Abbreviations: CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease.
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us